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Abstract
Background: Recently, immunotherapy has shown a lot of promise in cancer treatment and different immune cell
types are involved in this endeavor. Among different immune cell populations, NK cells are also an important component
in unleashing the therapeutic activity of immune cells. Therefore, in order to enhance the tumoricidal activity of NK cells,
identification of new small-molecule natural products is important. Despite the availability of different screening methods
for identification of natural products, a simple, economic and high-throughput method is lacking. Hence, in this study, we
have developed a high-throughput assay for screening and indentifying natural products that can enhance NK
cell-mediated killing of cancer cells.
Results: We expanded human NK cell population from human peripheral blood mononuclear cells (PBMCs) by
culturing these PBMCs with membrane-bound IL-21 and CD137L engineered K562 cells. Next, expanded NK cells
were co-cultured with non-small cell lung cancer (NSCLC) cells with or without natural products and after 24 h of
co-culturing, harvested supernatants were analyzed for IFN-γ secretions by ELISA method. We screened 502
natural products and identified that 28 candidates has the potential to induce IFN-γ secretion by NK cells to
varying degrees. Among the 28 natural product candidates, we further confirmed and analyzed the potential
of one molecule, andrographolide. It actually increased IFN-γ secretion by NK cells and enhanced NK cell-mediated
killing of NSCLC cells.
Conclusions: Our results demonstrated that this IFN-γ based high-throughput assay for screening of natural products
for NK cell tumoricidal activity is a simple, economic and reliable method.
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Background
Natural killer (NK) cells are derived from hematopoietic
progenitor cells and are abundantly present in bone
marrow, various organs and even in secondary lymphoid
tissues [1]. They constitute nearly 10–15 % of PBMCs
and are usually defined by expression of CD56 and
CD16 proteins, but lacks CD3 [2, 3]. NK cells are a
critical component of the innate immune response
against tumor cells and infections [4–6]. The tumoricidal
activity of NK cells is mediated by release of, a) various
cytokines such as IFN-γ and TNF-α, b) exocytosis of
granzymes (Perforin) containing lytic granules [7], and c)
expression of some death receptor ligands [8]. NK cells
recognition and destruction of tumor cells does not involve
prior sensitization in an MHC-I-unrestricted manner [9].
Thus, NK cells immunotherapy have shown a great poten-
tial in most of the hematopoietic malignancies [10].
There have been innumerable attempts over years to
use NK cell immunotherapy for the treatment of solid
cancers without much success. NK cells-mediated tar-
geting of solid tumor is usually not efficient despite of
the tumor cells expressing high amounts of activating
and low levels of inhibitory ligands [11]. This is attributed
to the creation of an immunosuppressive environment by
cancer cells to evade NK cell immune surveillance,
through secretion of factors like TGF-β [12, 13]. Thus, it
leads to poor prognosis [14]. The escape of tumor cells
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from immunosuppressive cells like NK cells, leads to the
failure of the immunotherapy especially for solid tumors
in the clinical settings. Hence, the development of new
drugs with ability to block the immunosuppressive envir-
onment is required to efficiently block the escaping of
tumor cells from immunosuppressive cell and will help in
restoring NK cell-mediated anti-tumor response [15].
Small-molecules isolated from natural products are a
major source for the development of new drugs. So far,
almost 50 % of all the new drugs were either natural prod-
ucts or their analogs, including those that modulate im-
mune cell functions [16]. Natural products that enhance
NK cell antitumor activity can block the escaping of
tumor cells from immune response and restore NK cell
mediated antitumor activity. However, lack of simple and
economic approach for large scale screening of the natural
products has been a big impediment and thus warrants a
development of a novel high-throughput assay for screen-
ing of novel and efficient small molecules from a pool of
thousands of natural products.
IFN-γ is a major cytokine secreted by activated NK
cells and exerts immune response against cancer and
virus-infected cells by inducing tumor apoptosis [17, 18].
IFN-γ has is a potent indicator of NK cell activity.
Bellucci R. et al. showed that silencing of 83 genes in
tumor cells resulted in enhanced IFN-γ release from
NKL cells and thus promoted apoptosis [19]. Similarly,
Lee SB. et al. also assessed NK cell activity as a function
of IFN-γ secretion in whole blood samples [20]. There-
fore, in this study, we also developed an IFN-γ based
high-throughput assay screen for assessing the effect of
small-molecule natural products on the tumoricidal ac-
tivity of NK cells. After screening 502 natural products,
we identified 28 candidates with a potential to enhance
NK cell activity and further confirmed that androgra-
pholide, one among the 28 natural products, actually
induced IFN-γ secretion by NK cells, and enhanced NK
cell mediated killing of cancer cells.
Results
Human NK Cell Expansion
In clinical application, there is always a requirement of
high number of NK cells and therefore, we first expanded
the NK cell population by an efficient system developed
by us previously for NK cell expansion [21]. The CD137L
and membrane-bound IL-21 engineered K562 were irradi-
ated and then co-incubated with PBMCs for 2 weeks.
Results showed that about 99 % of CD3−CD56+ cells were
NK cells after 2-week of expansion. Among these NK
cells, majority of them were CD56+CD16+ cells (>95 %)
(Fig. 1). These results were consistent with our previous
result, and indicated that these expanded NK cells were of
high purity, and were subsequently used for screening of
natural products (Fig. 2).
Optimization of Co-culturing Conditions for Maximum NK
Cell Tumoricidal Response
NK cells release IFN-γ after recognizing and binding to
the target cells. The level of IFN-γ production is directly
proportional with NK cell tumoricidal activity. Therefore,
we first optimized the E:T ratio of NK cells (effector) and
A549 tumor cells (target) for inducing efficient tumori-
cidal activity. Herein, we used IL-2 as a positive activa-
tor/stimulator to induce NK cells cytotoxic activity by
co-culturing them with target cells. We mixed lung
adenocarcinoma, A549 cells (5×103) per well together
with different ratios of NK cells (NK cells: A549
cells=0.5:1, 1:1, 2:1, 4:1) in 96-well plate either in the
presence or absence of 100U/mL of IL-2 for 24 h.
Subsequently, IFN-γ secretion was measured in the
supernatants. Results showed that secreted IFN-γ was
enhanced with the increasing ratio of NK cells to target
cells after IL-2 stimulation and peaked at 2:1 ratio
(Fig. 3). These results demonstrated that 0.5×104 of
A549 cells mixed with 1×104 of NK cells could elicit
maximal IFN-γ secretion after IL-2 stimulation, thus,
indicating that this E:T ratio is optimum for screening
of natural products.
Screening of Natural Products for Induction of NK Cell
Tumoricidal Activity
To determine the efficiency of 502 natural products to
induce NK cell tumoricidal activity, we plated 1×104 of
expanded NK cells from 3 donors and 5×103 of A549 cells
per well in 96-well plates. Thereafter, these co-cultured
cells were treated with each of the natural products at a
final concentration of 10 μM. At parallel, the cells were
also treated with equal volume of DMSO as negative
Fig. 1 Expansion of human NK cells. NK cells were expanded as
described in Methods section, and were stained with CD56, CD16
and CD3 antibodies for flow cytometry analysis. The data set presented
here is a representative of three independent experiments
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control and 100 U/mL of IL-2 as a positive control. We
arbitrarily used ≥ 40 % increase in IFN-γ secretion, in
comparison to the negative control, as efficient criteria.
Based on this criterion, we identified that 28 natural
products induced an efficient increase in IFN-γ secretion
(Fig. 4a). Comparison of IFN-γ secretion induced by 28
natural products and corresponding IL-2 stimulations,
we found that IFN-γ secretion by 5 natural products
were < 20 % of the levels induced by IL-2, whereas 14
natural products showed 20 %–50 % of the IFN-γ secre-
tion in comparison to IL-2 induction (Fig. 4b). Interest-
ingly, 2 natural products displayed 50 %–100 % of IFN-γ
secretion and 7 natural products had >100 % secretion in
comparison to IL-2 induced IFN-γ secretion. Among
these 7 natural products, 6 of them were protein kinase C
activators and another natural product was unknown.
Effect of Andrographolide on Viability of NK and NSCLC
Cells
Andrographolide, one among the 28 natural products,
has been found to suppress vascular angiogenesis and
tumor growth in our previous studies [22]. This led us
to further analyze this natural product and we investi-
gated its effects on NK cells and NSCLC cells viability.
Expanded NK cells and different NSCLC cell lines
(A549, H1299 and H1975) were treated with different
concentrations of andrographolide (0, 1, 5, 10, 25 and 50
μM). Results showed that all selected doses of androgra-
pholide did not impair NK cells viability at 24 h time
point. But 50 μM concentration of andrographolide had
20 % inhibition (p<0.05) at 48 h; and 10, 25 and 50 μM
of andrographolide had 15 %, 20 % and 30 % inhibition
(p<0.05) at 72 h (Fig. 5a). On the other hand, androgra-
pholide above 2.5 μM significantly (p<0.001) suppressed
the cell viability of all NSCLC cell lines at all time points
(Fig. 5b). These results thus indicate that andrographo-
lide has low toxicity towards expanded NK cells, but has
higher toxicity against NSCLC cells.
Role of Andrographolide in Inducing NK Cell Mediated
IFN-γ Secretion and Killing
Since low doses of andrographolide did not inhibit the
cells viability of expanded NK cells but had significant
suppression in NSCLC cells, we next focused on deter-
mining its effect on NK cell tumoricidal activity. We first
incubated NK cells and A549 cells together with differ-
ent concentrations of andrographolide for 24 h, and then
Fig. 2 The schematic presentation of IFN-γ based high-throughput assay for screening of natural products. To identify potent natural products, human NK
cells were first expanded, and then co-incubated with A549 cells in 96-well plates with or without natural products. After 24 h of co-culturing, supernatants
were harvested and IFN-γ levels were measured by ELISA assay
Fig. 3 Optimization of NK and target (A549) cells culturing conditions.
NK cells were co-cultured with A549 cells at different E:T ratios in 96-well
plates for 24 h, and then IFN-γ secretion in supernatant was detected by
ELISA assay. The data shown here is a representative of three
independent experiments. ***, P<0.001
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detected IFN-γ release by NK cells. The results showed
that andrographolide increased IFN-γ release, which was
not clearly dose-dependent (Fig. 6). Next, we determined
if andrographolide enhanced the NK cell-mediated lysis
of NSCLC cells by calcein release assay. Here we
pretreated the A549 and H1299 NSCLC cells with 5 and
10 μM of andrographolide for 24 h, respectively. Later
these andrographolide pretreated NSCLC cells were
incubated with untreated NK cells and we observed that
NK cells significantly enhanced the lysis of andrographo-
lide treated A549 and H1299 cells. Further, we pretreated
the NK cells with andrographolide and then incubated
them with untreated NSCLC cells, and again observed a
significant enhancement of NK cell mediated lysis of A549
cells and H1299 cells. Finally, we pretreated both NSCLC
cells and NK cells, respectively; and then incubated them
together, and observed this time also a significant en-
hancement of NK cell killing (Fig. 7a, b). Taken together,
these results indicated that andrographolide treatment has
the potential to enhance NK cell tumoricidal activity.
Discussion
In this study, we developed an IFN-γ-based high-
throughput screening assay to screen natural products
which might enhance NK cell mediated lysis of cancer
cells. By measuring the IFN-γ release by NK cells, we
totally screened 502 natural products and identified
that 28 natural products could increase IFN-γ release.
Fig. 4 Screening of natural products. Expanded NK cells were mixed with A549 cells in 96-well plates and natural products were added to a final
concentration of 10 μM. Panel a, represents percentage increase of IFN-γ after normalization to DMSO control. Panel b, represents IFN-γ
percentage ratio after normalization to IL-2 treatment
Fig. 5 Analysis of andrographolide effects on cell viability of NK and NSCLC cells. Expanded NK cells and NSCLC cells were treated with different
concentrations of andrographolide (Andro) for 24, 48 and 72 h, respectively. Panel a, represents NK cell viability as determined by CCK8 assay.
Panel b, represents NSCLC cell viability as assessed by MTT assay. Three independent experiments were performed. Data are expressed as
means ± S.E.M. *, P<0.05; **, P<0.01; ***, P<0.001
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Andrographolide, one among 28 natural products, dis-
played low toxicity in expanded NK cells but had higher
toxicity against different NSCLC cells. But, andrographo-
lide not only induced IFN-γ release but also enhanced NK
cell mediated killing of tumor cells. These results thus
established that the IFN-γ-based screening assay is a viable
option for screening and identifying natural products that
has the potential to enhance NK cell mediated killing of
cancer cells.
Previously published studies have shown that natural
products are a good source of compounds that can im-
prove NK cell anti-tumor response by enhancing NK cell
mediated recognition and killing of cancer cells [23–27].
However, it was hard to find efficient candidates from
millions of natural products [28]. Numbers of different
methods have been developed so far to detect NK cell
cytotoxicity. For example, Chromium 51 release assay is
the standard method to determine NK cells cytolytic
activity. In addition, CD107α degranulation assay and
several flow cytometric methods were also alternatively
used to determine NK cell cytotoxicity [29]. However
each of these assays had certain limitations, for example,
chromium 51 release assay were high-cost, involved
hazardous radioactivity and generated radioactive waste
[30], whereas CD107α degranulation assay and other
flow cytometric methods were time consuming and
involved high cost, and more importantly, all these
methods were not suitable for high-throughput analysis
[31]. Furthermore, these methods only focused on the
final NK cell killing activity on cancer cells, and totally
ignored, the inhibitory influence of cancer microenviron-
ment, such as IDO (Indoleamine-2,3-dioxygenase), PGE2
(Prostaglandin E2), and other factors secreted by cancer
cells against NK cells [32]. Therefore, the development of
a high-throughput screening assay that could mimic the
cancer microenvironment was necessary for identification
of natural products that has the potential to modulate NK
cell activity.
IFN-γ is a good indicator of NK cell cytotoxicity and
has been used to determine the NK cells anti-tumor
activity in whole blood [20]. In this study, we had devel-
oped an IFN-γ-based assay to determine NK cell killing
activity in an in vitro NK cell-cancer cell interacting
microenvironment. To get an optimal IFN-γ response,
we optimized E/T ratio and found the best E/T ratio
was 2. This E/T ratio may change in different cancer
model and was not equal to the best killing effect. In
Fig. 6 Andrographolide increased IFN-γ secretion by NK cells.
Expanded NK cells and A549 cells were co-cultured with various
concentrations (1 μM to 50 μM) of andrographolide. After 24 h,
IFN-γ release in supernatant was measured by ELISA method
Fig. 7 Andrographolide enhanced NK cell tumoricidal activity. NSCLC cells or NK cells were pretreated for 24 h with andrographolide, 5 and 10 μM
concentrations, respectively. Later NK cells cytotoxicity was evaluated by calcein release assay with a 5:1 ratio of effectors to target cells. Panel a, A549
cells; Panel b, H1299 cells. The data shown here are representative of three independent experiments. Data are expressed as means ± S.E.M. *, P<0.05;
**, P<0.01; ***, P<0.001
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fact, more NK cells may exert much higher killing
efficacy, but the IFN-γ response may be not optimal. As
shown in Fig. 3, INF-γ product become lower at E/T
ratio 4 compared to E/T ratio 2. We analyzed 502 nat-
ural products for induction of IFN-γ release by NK cells
and identified that 28 natural products induced 40 %
increase compared to no treatment. Among these nat-
ural products, 7 induced higher IFN-γ secretions than
IL-2 stimulation and out of these 7 natural products, 6
were protein kinase C activators. This result was consist-
ent with previous published reports that protein kinase
C activation could increase IFN-γ secretion [33], and
suggested that protein kinase C may be a good target for
natural products-induced NK cell activation [34, 35].
Andrographolide, one among the 28 natural products
had been demonstrated to have anti-inflammatory, anti-
cancer and angiogenesis activities both in vitro and in
vivo [22, 36]. In this study, andrographolide was shown
to have a low toxicity towards expanded NK cells, but
displayed higher toxicity against NSCLC cells, which
was consistent with its anti-tumor effects. In addition,
andrographolide really enhanced IFN-γ release by NK
cells and also NK cell-mediated killing of NSCLC cells,
and this enhancement was dose-independent. Dose-
independent effect is a common phenomenon. Fox
example, small-molecule antagonist BIO-1211 (Very
Late Antigen-4 (VLA4) blocker) results in reduced cyto-
kines expression, leukocyte trafficking, and inhibition of
inflammatory responses in EAE in a dose-independent
manner [37]. Of course, the mechanism is complicated
and additional experiments are needed to further define.
Taken together, our results suggested that andrographo-
lide might have a potent application in NK cell immuno-
therapy, and that the IFN-γ based high-throughput
screening assay can be a reliable method.
Conclusions
In this study, we developed a simple and economic, IFN-γ
based high-throughput screening assay to identify natural
products that could enhance the NK cells tumoricidal ac-
tivity. Furthermore, with the application of this assay, we
identified 28 natural product candidates. This high-
throughput screening assay might have valuable applica-
tion in NK cell-based drug discovery, and the 28 natural
product candidates can have potent application in modu-
lation of NK cell function and immunotherapy.
Methods
Reagents
APC anti-human CD56, FITC anti-human CD3, PE anti-
human CD16, murine isotype controls (IgG1κ-PE, IgG1κ-
FITC, IgG2a –APC) and human IFN-γ ELISA MAX™
Deluxe kit were purchased from BioLegend Inc. (San
Diego, CA). The recombinant human IL-2 protein was
obtained from PeproTech (Rehovot, Israel). Calcein-AM
was purchased from Sigma-Aldrich (St, Louis, MO).
CCK8 kit was purchased from YESAN (Shanghai, China).
NK Cell Expansion
Human peripheral blood mononuclear cells (PBMC) were
obtained from the Shanghai Blood Center under a re-
search protocol approved by the Department of Shanghai
Blood Administration. PBMCs were either freshly used or
frozen in 10 % DMSO containing fetal bovine serum (FBS,
Gibco). Frozen PBMCs were thawed, one day prior to
their cultivation in RPMI1640 medium supplemented with
10 % of fetal calf serum, 1 % of penicillin-streptomycin, 2
mM of L-Glutamine and 200 U/ml of IL-2 in 5 % CO2 at
37 °C. NK cells were expanded as described previously
[21]. Briefly, fresh or frozen PBMCs were co-incubated
with mbIL-21-CD137L-K562 cells which were pretreated
by 100 Gy irradiation for 2 weeks in RPMI1640 complete
medium in 5 % CO2 at 37 °C.
Flow Cytometry Analysis
Cells were incubated with CD56, CD16 and CD3 anti-
bodies conjugated with different fluorophores for 30 min
at 4 °C in dark, followed by washing, and resuspension
in PBS containing 1 % FBS. Data were acquired using a
BD Accuri C6 (BD Biosciences) and analyzed using the
FlowJo software (Ashland, OR).
Screening Assay
Total of 502 natural products were obtained from China
National Compound Resource Center (NCRC). The NK
cells (1×104) from 3 donors were mixed with A549 lung
adenocarcinoma cells (5×103) per well in 96-well plates.
These co-cultured cells were treated with natural prod-
ucts to a final concentration of 10 μM. Equal volume of
DMSO was added as negative control and 100 U/mL of
IL-2 was added as positive stimulator. After 24 h of in-
cubation, supernatants were harvested and IFN-γ was
measured by Human IFN-γ ELISA Kit following the
manufacturer’s instructions. Briefly, IFN-γ (capture)
antibody was incubated in 96-well plates at 4 °C over-
night. The plates were then washed 3 times with PBS
containing 0.1 % Tween-20, incubated with blocking
buffer for 1 h, and then washed 3 times again with PBS
containing 0.1 % Tween-20. Supernatant were added to
each well and incubated for 2 h, followed by washing of
plates again 3 times with PBS containing 0.1 % Tween-
20. Next, detection antibody was added and plates were
incubated for 1 h. At last, HRP reagent was added for
colorimetric detection of the signal and plates were read
at 450 nm using Synergy 2 Multi-Mode Microplate
Reader (BioTek Instruments, Inc., Winooski, VT).
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Cell Viability Assay
NK cells were seeded into 96-well plates at a density of
1×104 cells per well, and treated with different concentra-
tions of andrographolide for 24, 48 and 72 h. The cell
viability was measured by CCK8 kit following manufac-
turer’s instructions. Similarly, non-small cell lung cancer
(NSCLC) cells (5×103 per well) were seeded into 96-well
plates and treated with different concentrations of andro-
grapholide for 24, 48 and 72 h. After treatment, cells were
incubated with 500 μg/mL of MTT [3–(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide] for 4 h,
and the supernatants were removed. The plates were read
at 490 nm using Synergy 2 Multi-Mode Microplate Reader
(BioTek Instruments, Inc., Winooski, VT).
Calcein Release Assay
NK cells cytotoxicity were determined by using the calcein
release fluorometric assay [38, 39]. A549 cells were incu-
bated with 2 μg/mL of calcein-AM at 37 °C for 1 h with
occasional shaking. NK cells and A549 cells were mixed at
effector-to-target (E:T) ratio of 5:1 (5×104:1×104) and
co-cultured for 4 h. After incubation, 100 μL of super-
natant was transferred to a new plate. The fluorescence of
samples was measured with a Synergy 2 Multi-Mode
Microplate Reader (BioTek Instruments, Inc., Winooski,
VT) (excitation filter 485 nm, emission filter 538 nm).
The percentage lysis was calculated according to the
formula [(experimental release − spontaneous release)/
(maximum release − spontaneous release)] × 100.
Statistical Analysis
High-throughput screening assay was evaluated by Z’-
factor as described previously [29, 30]. Results with
Z’-factor below zero were discarded.
Z′ ¼ 1− 3  SDcþþ3  SDc−ð Þ= μcþ −μc−ð Þ
SDc+ standard deviation of IL-2 stimulated NK cell
activity
SDc− standard deviation based on level of NK cell
activity
μc+ mean of IL-2 stimulated NK cell activity
μc− mean based on level of NK cell activity
Results are expressed as the mean ± SEM. Statistical
comparison in two groups was performed by Student’s t-
test. P<0.05 represented statistical significant differences.
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